ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Precision Cancer Diagnostic Tests Market Insights, Forecast to 2030
Published Date: December 2024
|
Report Code: QYRE-Auto-38D5828
Home | Market Reports | Health| Medical Facilities & Services| Medical Procedures
Global Precision Cancer Diagnostic Tests Market Insights Forecast to 2028
BUY CHAPTERS

Global Precision Cancer Diagnostic Tests Market Insights, Forecast to 2030

Code: QYRE-Auto-38D5828
Report
December 2024
Pages:127
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Abbott Laboratories
Agilent Technologies
Becton Dickinson and Company
Bio Rad Laboratories
Biocartis N.V.
Biocept
BioMerieux SA
Canon Medical Systems Corporation
Cynvenio Biosystems
Danaher Corporation
Epigenomics
Exosome Diagnostics
Foundation Medicine
General Electric Company
Genomic Health
Hologic Inc
Illumina Inc
Menarini Silicon Biosystems SpA
Myriad Genetics
Nanostring Technologies
Ortho Clinical Diagnostics
QIAGEN N V
Randox Laboratories Ltd.
Roche Holding AG
Royal Philips N.V.
Siemens AG
Thermo Fisher Scientific
Vela Diagnostics

Precision Cancer Diagnostic Tests Market Size

The global Precision Cancer Diagnostic Tests market is projected to grow from US$ 4819 million in 2024 to US$ 9769.5 million by 2030, at a Compound Annual Growth Rate (CAGR) of 12.5% during the forecast period.

Precision Cancer Diagnostic Tests Market

Precision Cancer Diagnostic Tests Market

Precision cancer tests encompass imaging and in vitro diagnostic (IVD) products and procedures that directly detect malignancies in patient samples or in the patients themselves.
Market Analysis and Insights: Global Precision Cancer Diagnostic Tests Market
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers:
This report presents an overview of global market for Precision Cancer Diagnostic Tests market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Precision Cancer Diagnostic Tests, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Precision Cancer Diagnostic Tests, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Precision Cancer Diagnostic Tests revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Precision Cancer Diagnostic Tests market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Precision Cancer Diagnostic Tests revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation

Scope of Precision Cancer Diagnostic Tests Market Report

Report Metric Details
Report Name Precision Cancer Diagnostic Tests Market
Accounted market size in 2024 US$ 4819 million
Forecasted market size in 2030 US$ 9769.5 million
CAGR 12.5
Base Year 2024
Forecasted years 2025 - 2030
Segment by Type
Segment by Application
  • Hospital
  • Clinic
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Abbott Laboratories, Agilent Technologies, Becton Dickinson and Company, Bio-Rad Laboratories, Biocartis N.V., Biocept, bioMerieux SA, Canon Medical Systems Corporation, Cynvenio Biosystems, Danaher Corporation, Epigenomics AG, Exosome Diagnostics, Foundation Medicine, General Electric Company, Genomic Health, Hologic, Illumina, Menarini Silicon Biosystems SpA, Myriad Genetics, NanoString Technologies, Ortho Clinical Diagnostics, QIAGEN N.V., Randox Laboratories Ltd., Roche Holding AG, Royal Philips N.V., Siemens AG, Thermo Fisher Scientific, Vela Diagnostics
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Revenue of Precision Cancer Diagnostic Tests in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Precision Cancer Diagnostic Tests companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
  • Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
  • Chapter 8: China by Type, and by Application, revenue for each segment.
  • Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
  • Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
  • Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Precision Cancer Diagnostic Tests revenue, gross margin, and recent development, etc.
  • Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

How fast is Precision Cancer Diagnostic Tests Market growing?

Ans: The Precision Cancer Diagnostic Tests Market witnessing a CAGR of 12.5 during the forecast period 2025-2030.

What is the Precision Cancer Diagnostic Tests Market size in 2030?

Ans: The Precision Cancer Diagnostic Tests Market size in 2030 will be US$ 9769.5 million.

Who are the main players in the Precision Cancer Diagnostic Tests Market report?

Ans: The main players in the Precision Cancer Diagnostic Tests Market are Abbott Laboratories, Agilent Technologies, Becton Dickinson and Company, Bio-Rad Laboratories, Biocartis N.V., Biocept, bioMerieux SA, Canon Medical Systems Corporation, Cynvenio Biosystems, Danaher Corporation, Epigenomics AG, Exosome Diagnostics, Foundation Medicine, General Electric Company, Genomic Health, Hologic, Illumina, Menarini Silicon Biosystems SpA, Myriad Genetics, NanoString Technologies, Ortho Clinical Diagnostics, QIAGEN N.V., Randox Laboratories Ltd., Roche Holding AG, Royal Philips N.V., Siemens AG, Thermo Fisher Scientific, Vela Diagnostics

What are the Application segmentation covered in the Precision Cancer Diagnostic Tests Market report?

Ans: The Applications covered in the Precision Cancer Diagnostic Tests Market report are Hospital, Clinic, Other

What are the Type segmentation covered in the Precision Cancer Diagnostic Tests Market report?

Ans: The Types covered in the Precision Cancer Diagnostic Tests Market report are Imaging, Molecular, Histology/Cytology, Tumor Marker Immunoassays, POC Colon Cancer Tests

Recommended Reports

Cancer Diagnostics

Cancer Molecular Testing

Precision Medicine

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Precision Cancer Diagnostic Tests Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Imaging
1.2.3 Molecular
1.2.4 Histology/Cytology
1.2.5 Tumor Marker Immunoassays
1.2.6 POC Colon Cancer Tests
1.3 Market by Application
1.3.1 Global Precision Cancer Diagnostic Tests Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Precision Cancer Diagnostic Tests Market Perspective (2019-2030)
2.2 Global Precision Cancer Diagnostic Tests Growth Trends by Region
2.2.1 Precision Cancer Diagnostic Tests Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Precision Cancer Diagnostic Tests Historic Market Size by Region (2019-2024)
2.2.3 Precision Cancer Diagnostic Tests Forecasted Market Size by Region (2025-2030)
2.3 Precision Cancer Diagnostic Tests Market Dynamics
2.3.1 Precision Cancer Diagnostic Tests Industry Trends
2.3.2 Precision Cancer Diagnostic Tests Market Drivers
2.3.3 Precision Cancer Diagnostic Tests Market Challenges
2.3.4 Precision Cancer Diagnostic Tests Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Precision Cancer Diagnostic Tests by Players
3.1.1 Global Precision Cancer Diagnostic Tests Revenue by Players (2019-2024)
3.1.2 Global Precision Cancer Diagnostic Tests Revenue Market Share by Players (2019-2024)
3.2 Global Precision Cancer Diagnostic Tests Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Precision Cancer Diagnostic Tests, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Precision Cancer Diagnostic Tests Market Concentration Ratio
3.4.1 Global Precision Cancer Diagnostic Tests Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Precision Cancer Diagnostic Tests Revenue in 2023
3.5 Global Key Players of Precision Cancer Diagnostic Tests Head office and Area Served
3.6 Global Key Players of Precision Cancer Diagnostic Tests, Product and Application
3.7 Global Key Players of Precision Cancer Diagnostic Tests, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Precision Cancer Diagnostic Tests Breakdown Data by Type
4.1 Global Precision Cancer Diagnostic Tests Historic Market Size by Type (2019-2024)
4.2 Global Precision Cancer Diagnostic Tests Forecasted Market Size by Type (2025-2030)
5 Precision Cancer Diagnostic Tests Breakdown Data by Application
5.1 Global Precision Cancer Diagnostic Tests Historic Market Size by Application (2019-2024)
5.2 Global Precision Cancer Diagnostic Tests Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Precision Cancer Diagnostic Tests Market Size (2019-2030)
6.2 North America Precision Cancer Diagnostic Tests Market Size by Type
6.2.1 North America Precision Cancer Diagnostic Tests Market Size by Type (2019-2024)
6.2.2 North America Precision Cancer Diagnostic Tests Market Size by Type (2025-2030)
6.2.3 North America Precision Cancer Diagnostic Tests Market Share by Type (2019-2030)
6.3 North America Precision Cancer Diagnostic Tests Market Size by Application
6.3.1 North America Precision Cancer Diagnostic Tests Market Size by Application (2019-2024)
6.3.2 North America Precision Cancer Diagnostic Tests Market Size by Application (2025-2030)
6.3.3 North America Precision Cancer Diagnostic Tests Market Share by Application (2019-2030)
6.4 North America Precision Cancer Diagnostic Tests Market Size by Country
6.4.1 North America Precision Cancer Diagnostic Tests Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Precision Cancer Diagnostic Tests Market Size by Country (2019-2024)
6.4.3 North America Precision Cancer Diagnostic Tests Market Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Precision Cancer Diagnostic Tests Market Size (2019-2030)
7.2 Europe Precision Cancer Diagnostic Tests Market Size by Type
7.2.1 Europe Precision Cancer Diagnostic Tests Market Size by Type (2019-2024)
7.2.2 Europe Precision Cancer Diagnostic Tests Market Size by Type (2025-2030)
7.2.3 Europe Precision Cancer Diagnostic Tests Market Share by Type (2019-2030)
7.3 Europe Precision Cancer Diagnostic Tests Market Size by Application
7.3.1 Europe Precision Cancer Diagnostic Tests Market Size by Application (2019-2024)
7.3.2 Europe Precision Cancer Diagnostic Tests Market Size by Application (2025-2030)
7.3.3 Europe Precision Cancer Diagnostic Tests Market Share by Application (2019-2030)
7.4 Europe Precision Cancer Diagnostic Tests Market Size by Country
7.4.1 Europe Precision Cancer Diagnostic Tests Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Precision Cancer Diagnostic Tests Market Size by Country (2019-2024)
7.4.3 Europe Precision Cancer Diagnostic Tests Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Precision Cancer Diagnostic Tests Market Size (2019-2030)
8.2 China Precision Cancer Diagnostic Tests Market Size by Type
8.2.1 China Precision Cancer Diagnostic Tests Market Size by Type (2019-2024)
8.2.2 China Precision Cancer Diagnostic Tests Market Size by Type (2025-2030)
8.2.3 China Precision Cancer Diagnostic Tests Market Share by Type (2019-2030)
8.3 China Precision Cancer Diagnostic Tests Market Size by Application
8.3.1 China Precision Cancer Diagnostic Tests Market Size by Application (2019-2024)
8.3.2 China Precision Cancer Diagnostic Tests Market Size by Application (2025-2030)
8.3.3 China Precision Cancer Diagnostic Tests Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Precision Cancer Diagnostic Tests Market Size (2019-2030)
9.2 Asia Precision Cancer Diagnostic Tests Market Size by Type
9.2.1 Asia Precision Cancer Diagnostic Tests Market Size by Type (2019-2024)
9.2.2 Asia Precision Cancer Diagnostic Tests Market Size by Type (2025-2030)
9.2.3 Asia Precision Cancer Diagnostic Tests Market Share by Type (2019-2030)
9.3 Asia Precision Cancer Diagnostic Tests Market Size by Application
9.3.1 Asia Precision Cancer Diagnostic Tests Market Size by Application (2019-2024)
9.3.2 Asia Precision Cancer Diagnostic Tests Market Size by Application (2025-2030)
9.3.3 Asia Precision Cancer Diagnostic Tests Market Share by Application (2019-2030)
9.4 Asia Precision Cancer Diagnostic Tests Market Size by Region
9.4.1 Asia Precision Cancer Diagnostic Tests Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Precision Cancer Diagnostic Tests Market Size by Region (2019-2024)
9.4.3 Asia Precision Cancer Diagnostic Tests Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Precision Cancer Diagnostic Tests Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Precision Cancer Diagnostic Tests Market Size by Type
10.2.1 Middle East, Africa, and Latin America Precision Cancer Diagnostic Tests Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Precision Cancer Diagnostic Tests Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Precision Cancer Diagnostic Tests Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Precision Cancer Diagnostic Tests Market Size by Application
10.3.1 Middle East, Africa, and Latin America Precision Cancer Diagnostic Tests Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Precision Cancer Diagnostic Tests Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Precision Cancer Diagnostic Tests Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Precision Cancer Diagnostic Tests Market Size by Country
10.4.1 Middle East, Africa, and Latin America Precision Cancer Diagnostic Tests Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Precision Cancer Diagnostic Tests Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Precision Cancer Diagnostic Tests Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Details
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Precision Cancer Diagnostic Tests Introduction
11.1.4 Abbott Laboratories Revenue in Precision Cancer Diagnostic Tests Business (2019-2024)
11.1.5 Abbott Laboratories Recent Developments
11.2 Agilent Technologies
11.2.1 Agilent Technologies Company Details
11.2.2 Agilent Technologies Business Overview
11.2.3 Agilent Technologies Precision Cancer Diagnostic Tests Introduction
11.2.4 Agilent Technologies Revenue in Precision Cancer Diagnostic Tests Business (2019-2024)
11.2.5 Agilent Technologies Recent Developments
11.3 Becton Dickinson and Company
11.3.1 Becton Dickinson and Company Company Details
11.3.2 Becton Dickinson and Company Business Overview
11.3.3 Becton Dickinson and Company Precision Cancer Diagnostic Tests Introduction
11.3.4 Becton Dickinson and Company Revenue in Precision Cancer Diagnostic Tests Business (2019-2024)
11.3.5 Becton Dickinson and Company Recent Developments
11.4 Bio-Rad Laboratories
11.4.1 Bio-Rad Laboratories Company Details
11.4.2 Bio-Rad Laboratories Business Overview
11.4.3 Bio-Rad Laboratories Precision Cancer Diagnostic Tests Introduction
11.4.4 Bio-Rad Laboratories Revenue in Precision Cancer Diagnostic Tests Business (2019-2024)
11.4.5 Bio-Rad Laboratories Recent Developments
11.5 Biocartis N.V.
11.5.1 Biocartis N.V. Company Details
11.5.2 Biocartis N.V. Business Overview
11.5.3 Biocartis N.V. Precision Cancer Diagnostic Tests Introduction
11.5.4 Biocartis N.V. Revenue in Precision Cancer Diagnostic Tests Business (2019-2024)
11.5.5 Biocartis N.V. Recent Developments
11.6 Biocept
11.6.1 Biocept Company Details
11.6.2 Biocept Business Overview
11.6.3 Biocept Precision Cancer Diagnostic Tests Introduction
11.6.4 Biocept Revenue in Precision Cancer Diagnostic Tests Business (2019-2024)
11.6.5 Biocept Recent Developments
11.7 bioMerieux SA
11.7.1 bioMerieux SA Company Details
11.7.2 bioMerieux SA Business Overview
11.7.3 bioMerieux SA Precision Cancer Diagnostic Tests Introduction
11.7.4 bioMerieux SA Revenue in Precision Cancer Diagnostic Tests Business (2019-2024)
11.7.5 bioMerieux SA Recent Developments
11.8 Canon Medical Systems Corporation
11.8.1 Canon Medical Systems Corporation Company Details
11.8.2 Canon Medical Systems Corporation Business Overview
11.8.3 Canon Medical Systems Corporation Precision Cancer Diagnostic Tests Introduction
11.8.4 Canon Medical Systems Corporation Revenue in Precision Cancer Diagnostic Tests Business (2019-2024)
11.8.5 Canon Medical Systems Corporation Recent Developments
11.9 Cynvenio Biosystems
11.9.1 Cynvenio Biosystems Company Details
11.9.2 Cynvenio Biosystems Business Overview
11.9.3 Cynvenio Biosystems Precision Cancer Diagnostic Tests Introduction
11.9.4 Cynvenio Biosystems Revenue in Precision Cancer Diagnostic Tests Business (2019-2024)
11.9.5 Cynvenio Biosystems Recent Developments
11.10 Danaher Corporation
11.10.1 Danaher Corporation Company Details
11.10.2 Danaher Corporation Business Overview
11.10.3 Danaher Corporation Precision Cancer Diagnostic Tests Introduction
11.10.4 Danaher Corporation Revenue in Precision Cancer Diagnostic Tests Business (2019-2024)
11.10.5 Danaher Corporation Recent Developments
11.11 Epigenomics AG
11.11.1 Epigenomics AG Company Details
11.11.2 Epigenomics AG Business Overview
11.11.3 Epigenomics AG Precision Cancer Diagnostic Tests Introduction
11.11.4 Epigenomics AG Revenue in Precision Cancer Diagnostic Tests Business (2019-2024)
11.11.5 Epigenomics AG Recent Developments
11.12 Exosome Diagnostics
11.12.1 Exosome Diagnostics Company Details
11.12.2 Exosome Diagnostics Business Overview
11.12.3 Exosome Diagnostics Precision Cancer Diagnostic Tests Introduction
11.12.4 Exosome Diagnostics Revenue in Precision Cancer Diagnostic Tests Business (2019-2024)
11.12.5 Exosome Diagnostics Recent Developments
11.13 Foundation Medicine
11.13.1 Foundation Medicine Company Details
11.13.2 Foundation Medicine Business Overview
11.13.3 Foundation Medicine Precision Cancer Diagnostic Tests Introduction
11.13.4 Foundation Medicine Revenue in Precision Cancer Diagnostic Tests Business (2019-2024)
11.13.5 Foundation Medicine Recent Developments
11.14 General Electric Company
11.14.1 General Electric Company Company Details
11.14.2 General Electric Company Business Overview
11.14.3 General Electric Company Precision Cancer Diagnostic Tests Introduction
11.14.4 General Electric Company Revenue in Precision Cancer Diagnostic Tests Business (2019-2024)
11.14.5 General Electric Company Recent Developments
11.15 Genomic Health
11.15.1 Genomic Health Company Details
11.15.2 Genomic Health Business Overview
11.15.3 Genomic Health Precision Cancer Diagnostic Tests Introduction
11.15.4 Genomic Health Revenue in Precision Cancer Diagnostic Tests Business (2019-2024)
11.15.5 Genomic Health Recent Developments
11.16 Hologic
11.16.1 Hologic Company Details
11.16.2 Hologic Business Overview
11.16.3 Hologic Precision Cancer Diagnostic Tests Introduction
11.16.4 Hologic Revenue in Precision Cancer Diagnostic Tests Business (2019-2024)
11.16.5 Hologic Recent Developments
11.17 Illumina
11.17.1 Illumina Company Details
11.17.2 Illumina Business Overview
11.17.3 Illumina Precision Cancer Diagnostic Tests Introduction
11.17.4 Illumina Revenue in Precision Cancer Diagnostic Tests Business (2019-2024)
11.17.5 Illumina Recent Developments
11.18 Menarini Silicon Biosystems SpA
11.18.1 Menarini Silicon Biosystems SpA Company Details
11.18.2 Menarini Silicon Biosystems SpA Business Overview
11.18.3 Menarini Silicon Biosystems SpA Precision Cancer Diagnostic Tests Introduction
11.18.4 Menarini Silicon Biosystems SpA Revenue in Precision Cancer Diagnostic Tests Business (2019-2024)
11.18.5 Menarini Silicon Biosystems SpA Recent Developments
11.19 Myriad Genetics
11.19.1 Myriad Genetics Company Details
11.19.2 Myriad Genetics Business Overview
11.19.3 Myriad Genetics Precision Cancer Diagnostic Tests Introduction
11.19.4 Myriad Genetics Revenue in Precision Cancer Diagnostic Tests Business (2019-2024)
11.19.5 Myriad Genetics Recent Developments
11.20 NanoString Technologies
11.20.1 NanoString Technologies Company Details
11.20.2 NanoString Technologies Business Overview
11.20.3 NanoString Technologies Precision Cancer Diagnostic Tests Introduction
11.20.4 NanoString Technologies Revenue in Precision Cancer Diagnostic Tests Business (2019-2024)
11.20.5 NanoString Technologies Recent Developments
11.21 Ortho Clinical Diagnostics
11.21.1 Ortho Clinical Diagnostics Company Details
11.21.2 Ortho Clinical Diagnostics Business Overview
11.21.3 Ortho Clinical Diagnostics Precision Cancer Diagnostic Tests Introduction
11.21.4 Ortho Clinical Diagnostics Revenue in Precision Cancer Diagnostic Tests Business (2019-2024)
11.21.5 Ortho Clinical Diagnostics Recent Developments
11.22 QIAGEN N.V.
11.22.1 QIAGEN N.V. Company Details
11.22.2 QIAGEN N.V. Business Overview
11.22.3 QIAGEN N.V. Precision Cancer Diagnostic Tests Introduction
11.22.4 QIAGEN N.V. Revenue in Precision Cancer Diagnostic Tests Business (2019-2024)
11.22.5 QIAGEN N.V. Recent Developments
11.23 Randox Laboratories Ltd.
11.23.1 Randox Laboratories Ltd. Company Details
11.23.2 Randox Laboratories Ltd. Business Overview
11.23.3 Randox Laboratories Ltd. Precision Cancer Diagnostic Tests Introduction
11.23.4 Randox Laboratories Ltd. Revenue in Precision Cancer Diagnostic Tests Business (2019-2024)
11.23.5 Randox Laboratories Ltd. Recent Developments
11.24 Roche Holding AG
11.24.1 Roche Holding AG Company Details
11.24.2 Roche Holding AG Business Overview
11.24.3 Roche Holding AG Precision Cancer Diagnostic Tests Introduction
11.24.4 Roche Holding AG Revenue in Precision Cancer Diagnostic Tests Business (2019-2024)
11.24.5 Roche Holding AG Recent Developments
11.25 Royal Philips N.V.
11.25.1 Royal Philips N.V. Company Details
11.25.2 Royal Philips N.V. Business Overview
11.25.3 Royal Philips N.V. Precision Cancer Diagnostic Tests Introduction
11.25.4 Royal Philips N.V. Revenue in Precision Cancer Diagnostic Tests Business (2019-2024)
11.25.5 Royal Philips N.V. Recent Developments
11.26 Siemens AG
11.26.1 Siemens AG Company Details
11.26.2 Siemens AG Business Overview
11.26.3 Siemens AG Precision Cancer Diagnostic Tests Introduction
11.26.4 Siemens AG Revenue in Precision Cancer Diagnostic Tests Business (2019-2024)
11.26.5 Siemens AG Recent Developments
11.27 Thermo Fisher Scientific
11.27.1 Thermo Fisher Scientific Company Details
11.27.2 Thermo Fisher Scientific Business Overview
11.27.3 Thermo Fisher Scientific Precision Cancer Diagnostic Tests Introduction
11.27.4 Thermo Fisher Scientific Revenue in Precision Cancer Diagnostic Tests Business (2019-2024)
11.27.5 Thermo Fisher Scientific Recent Developments
11.28 Vela Diagnostics
11.28.1 Vela Diagnostics Company Details
11.28.2 Vela Diagnostics Business Overview
11.28.3 Vela Diagnostics Precision Cancer Diagnostic Tests Introduction
11.28.4 Vela Diagnostics Revenue in Precision Cancer Diagnostic Tests Business (2019-2024)
11.28.5 Vela Diagnostics Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
FEATURED COMPANIES
Abbott Laboratories
Agilent Technologies
Becton Dickinson and Company
Bio Rad Laboratories
Biocartis N.V.
Biocept
BioMerieux SA
Canon Medical Systems Corporation
Cynvenio Biosystems
Danaher Corporation
Epigenomics
Exosome Diagnostics
Foundation Medicine
General Electric Company
Genomic Health
Hologic Inc
Illumina Inc
Menarini Silicon Biosystems SpA
Myriad Genetics
Nanostring Technologies
Ortho Clinical Diagnostics
QIAGEN N V
Randox Laboratories Ltd.
Roche Holding AG
Royal Philips N.V.
Siemens AG
Thermo Fisher Scientific
Vela Diagnostics
List of Tables
    Table 1. Global Precision Cancer Diagnostic Tests Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
    Table 2. Key Players of Imaging
    Table 3. Key Players of Molecular
    Table 4. Key Players of Histology/Cytology
    Table 5. Key Players of Tumor Marker Immunoassays
    Table 6. Key Players of POC Colon Cancer Tests
    Table 7. Global Precision Cancer Diagnostic Tests Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
    Table 8. Global Precision Cancer Diagnostic Tests Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 9. Global Precision Cancer Diagnostic Tests Market Size by Region (2019-2024) & (US$ Million)
    Table 10. Global Precision Cancer Diagnostic Tests Market Share by Region (2019-2024)
    Table 11. Global Precision Cancer Diagnostic Tests Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 12. Global Precision Cancer Diagnostic Tests Market Share by Region (2025-2030)
    Table 13. Precision Cancer Diagnostic Tests Market Trends
    Table 14. Precision Cancer Diagnostic Tests Market Drivers
    Table 15. Precision Cancer Diagnostic Tests Market Challenges
    Table 16. Precision Cancer Diagnostic Tests Market Restraints
    Table 17. Global Precision Cancer Diagnostic Tests Revenue by Players (2019-2024) & (US$ Million)
    Table 18. Global Precision Cancer Diagnostic Tests Revenue Share by Players (2019-2024)
    Table 19. Global Top Precision Cancer Diagnostic Tests by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Precision Cancer Diagnostic Tests as of 2023)
    Table 20. Global Precision Cancer Diagnostic Tests Industry Ranking 2022 VS 2023 VS 2024
    Table 21. Global 5 Largest Players Market Share by Precision Cancer Diagnostic Tests Revenue (CR5 and HHI) & (2019-2024)
    Table 22. Global Key Players of Precision Cancer Diagnostic Tests, Headquarters and Area Served
    Table 23. Global Key Players of Precision Cancer Diagnostic Tests, Product and Application
    Table 24. Global Key Players of Precision Cancer Diagnostic Tests, Product and Application
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Precision Cancer Diagnostic Tests Market Size by Type (2019-2024) & (US$ Million)
    Table 27. Global Precision Cancer Diagnostic Tests Revenue Market Share by Type (2019-2024)
    Table 28. Global Precision Cancer Diagnostic Tests Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 29. Global Precision Cancer Diagnostic Tests Revenue Market Share by Type (2025-2030)
    Table 30. Global Precision Cancer Diagnostic Tests Market Size by Application (2019-2024) & (US$ Million)
    Table 31. Global Precision Cancer Diagnostic Tests Revenue Share by Application (2019-2024)
    Table 32. Global Precision Cancer Diagnostic Tests Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 33. Global Precision Cancer Diagnostic Tests Revenue Share by Application (2025-2030)
    Table 34. North America Precision Cancer Diagnostic Tests Market Size by Type (2019-2024) & (US$ Million)
    Table 35. North America Precision Cancer Diagnostic Tests Market Size by Type (2025-2030) & (US$ Million)
    Table 36. North America Precision Cancer Diagnostic Tests Market Size by Application (2019-2024) & (US$ Million)
    Table 37. North America Precision Cancer Diagnostic Tests Market Size by Application (2025-2030) & (US$ Million)
    Table 38. North America Precision Cancer Diagnostic Tests Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 39. North America Precision Cancer Diagnostic Tests Market Size by Country (2019-2024) & (US$ Million)
    Table 40. North America Precision Cancer Diagnostic Tests Market Size by Country (2025-2030) & (US$ Million)
    Table 41. Europe Precision Cancer Diagnostic Tests Market Size by Type (2019-2024) & (US$ Million)
    Table 42. Europe Precision Cancer Diagnostic Tests Market Size by Type (2025-2030) & (US$ Million)
    Table 43. Europe Precision Cancer Diagnostic Tests Market Size by Application (2019-2024) & (US$ Million)
    Table 44. Europe Precision Cancer Diagnostic Tests Market Size by Application (2025-2030) & (US$ Million)
    Table 45. Europe Precision Cancer Diagnostic Tests Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 46. Europe Precision Cancer Diagnostic Tests Market Size by Country (2019-2024) & (US$ Million)
    Table 47. Europe Precision Cancer Diagnostic Tests Market Size by Country (2025-2030) & (US$ Million)
    Table 48. China Precision Cancer Diagnostic Tests Market Size by Type (2019-2024) & (US$ Million)
    Table 49. China Precision Cancer Diagnostic Tests Market Size by Type (2025-2030) & (US$ Million)
    Table 50. China Precision Cancer Diagnostic Tests Market Size by Application (2019-2024) & (US$ Million)
    Table 51. China Precision Cancer Diagnostic Tests Market Size by Application (2025-2030) & (US$ Million)
    Table 52. Asia Precision Cancer Diagnostic Tests Market Size by Type (2019-2024) & (US$ Million)
    Table 53. Asia Precision Cancer Diagnostic Tests Market Size by Type (2025-2030) & (US$ Million)
    Table 54. Asia Precision Cancer Diagnostic Tests Market Size by Application (2019-2024) & (US$ Million)
    Table 55. Asia Precision Cancer Diagnostic Tests Market Size by Application (2025-2030) & (US$ Million)
    Table 56. Asia Precision Cancer Diagnostic Tests Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 57. Asia Precision Cancer Diagnostic Tests Market Size by Region (2019-2024) & (US$ Million)
    Table 58. Asia Precision Cancer Diagnostic Tests Market Size by Region (2025-2030) & (US$ Million)
    Table 59. Middle East, Africa, and Latin America Precision Cancer Diagnostic Tests Market Size by Type (2019-2024) & (US$ Million)
    Table 60. Middle East, Africa, and Latin America Precision Cancer Diagnostic Tests Market Size by Type (2025-2030) & (US$ Million)
    Table 61. Middle East, Africa, and Latin America Precision Cancer Diagnostic Tests Market Size by Application (2019-2024) & (US$ Million)
    Table 62. Middle East, Africa, and Latin America Precision Cancer Diagnostic Tests Market Size by Application (2025-2030) & (US$ Million)
    Table 63. Middle East, Africa, and Latin America Precision Cancer Diagnostic Tests Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 64. Middle East, Africa, and Latin America Precision Cancer Diagnostic Tests Market Size by Country (2019-2024) & (US$ Million)
    Table 65. Middle East, Africa, and Latin America Precision Cancer Diagnostic Tests Market Size by Country (2025-2030) & (US$ Million)
    Table 66. Abbott Laboratories Company Details
    Table 67. Abbott Laboratories Business Overview
    Table 68. Abbott Laboratories Precision Cancer Diagnostic Tests Product
    Table 69. Abbott Laboratories Revenue in Precision Cancer Diagnostic Tests Business (2019-2024) & (US$ Million)
    Table 70. Abbott Laboratories Recent Developments
    Table 71. Agilent Technologies Company Details
    Table 72. Agilent Technologies Business Overview
    Table 73. Agilent Technologies Precision Cancer Diagnostic Tests Product
    Table 74. Agilent Technologies Revenue in Precision Cancer Diagnostic Tests Business (2019-2024) & (US$ Million)
    Table 75. Agilent Technologies Recent Developments
    Table 76. Becton Dickinson and Company Company Details
    Table 77. Becton Dickinson and Company Business Overview
    Table 78. Becton Dickinson and Company Precision Cancer Diagnostic Tests Product
    Table 79. Becton Dickinson and Company Revenue in Precision Cancer Diagnostic Tests Business (2019-2024) & (US$ Million)
    Table 80. Becton Dickinson and Company Recent Developments
    Table 81. Bio-Rad Laboratories Company Details
    Table 82. Bio-Rad Laboratories Business Overview
    Table 83. Bio-Rad Laboratories Precision Cancer Diagnostic Tests Product
    Table 84. Bio-Rad Laboratories Revenue in Precision Cancer Diagnostic Tests Business (2019-2024) & (US$ Million)
    Table 85. Bio-Rad Laboratories Recent Developments
    Table 86. Biocartis N.V. Company Details
    Table 87. Biocartis N.V. Business Overview
    Table 88. Biocartis N.V. Precision Cancer Diagnostic Tests Product
    Table 89. Biocartis N.V. Revenue in Precision Cancer Diagnostic Tests Business (2019-2024) & (US$ Million)
    Table 90. Biocartis N.V. Recent Developments
    Table 91. Biocept Company Details
    Table 92. Biocept Business Overview
    Table 93. Biocept Precision Cancer Diagnostic Tests Product
    Table 94. Biocept Revenue in Precision Cancer Diagnostic Tests Business (2019-2024) & (US$ Million)
    Table 95. Biocept Recent Developments
    Table 96. bioMerieux SA Company Details
    Table 97. bioMerieux SA Business Overview
    Table 98. bioMerieux SA Precision Cancer Diagnostic Tests Product
    Table 99. bioMerieux SA Revenue in Precision Cancer Diagnostic Tests Business (2019-2024) & (US$ Million)
    Table 100. bioMerieux SA Recent Developments
    Table 101. Canon Medical Systems Corporation Company Details
    Table 102. Canon Medical Systems Corporation Business Overview
    Table 103. Canon Medical Systems Corporation Precision Cancer Diagnostic Tests Product
    Table 104. Canon Medical Systems Corporation Revenue in Precision Cancer Diagnostic Tests Business (2019-2024) & (US$ Million)
    Table 105. Canon Medical Systems Corporation Recent Developments
    Table 106. Cynvenio Biosystems Company Details
    Table 107. Cynvenio Biosystems Business Overview
    Table 108. Cynvenio Biosystems Precision Cancer Diagnostic Tests Product
    Table 109. Cynvenio Biosystems Revenue in Precision Cancer Diagnostic Tests Business (2019-2024) & (US$ Million)
    Table 110. Cynvenio Biosystems Recent Developments
    Table 111. Danaher Corporation Company Details
    Table 112. Danaher Corporation Business Overview
    Table 113. Danaher Corporation Precision Cancer Diagnostic Tests Product
    Table 114. Danaher Corporation Revenue in Precision Cancer Diagnostic Tests Business (2019-2024) & (US$ Million)
    Table 115. Danaher Corporation Recent Developments
    Table 116. Epigenomics AG Company Details
    Table 117. Epigenomics AG Business Overview
    Table 118. Epigenomics AG Precision Cancer Diagnostic Tests Product
    Table 119. Epigenomics AG Revenue in Precision Cancer Diagnostic Tests Business (2019-2024) & (US$ Million)
    Table 120. Epigenomics AG Recent Developments
    Table 121. Exosome Diagnostics Company Details
    Table 122. Exosome Diagnostics Business Overview
    Table 123. Exosome Diagnostics Precision Cancer Diagnostic Tests Product
    Table 124. Exosome Diagnostics Revenue in Precision Cancer Diagnostic Tests Business (2019-2024) & (US$ Million)
    Table 125. Exosome Diagnostics Recent Developments
    Table 126. Foundation Medicine Company Details
    Table 127. Foundation Medicine Business Overview
    Table 128. Foundation Medicine Precision Cancer Diagnostic Tests Product
    Table 129. Foundation Medicine Revenue in Precision Cancer Diagnostic Tests Business (2019-2024) & (US$ Million)
    Table 130. Foundation Medicine Recent Developments
    Table 131. General Electric Company Company Details
    Table 132. General Electric Company Business Overview
    Table 133. General Electric Company Precision Cancer Diagnostic Tests Product
    Table 134. General Electric Company Revenue in Precision Cancer Diagnostic Tests Business (2019-2024) & (US$ Million)
    Table 135. General Electric Company Recent Developments
    Table 136. Genomic Health Company Details
    Table 137. Genomic Health Business Overview
    Table 138. Genomic Health Precision Cancer Diagnostic Tests Product
    Table 139. Genomic Health Revenue in Precision Cancer Diagnostic Tests Business (2019-2024) & (US$ Million)
    Table 140. Genomic Health Recent Developments
    Table 141. Hologic Company Details
    Table 142. Hologic Business Overview
    Table 143. Hologic Precision Cancer Diagnostic Tests Product
    Table 144. Hologic Revenue in Precision Cancer Diagnostic Tests Business (2019-2024) & (US$ Million)
    Table 145. Hologic Recent Developments
    Table 146. Illumina Company Details
    Table 147. Illumina Business Overview
    Table 148. Illumina Precision Cancer Diagnostic Tests Product
    Table 149. Illumina Revenue in Precision Cancer Diagnostic Tests Business (2019-2024) & (US$ Million)
    Table 150. Illumina Recent Developments
    Table 151. Menarini Silicon Biosystems SpA Company Details
    Table 152. Menarini Silicon Biosystems SpA Business Overview
    Table 153. Menarini Silicon Biosystems SpA Precision Cancer Diagnostic Tests Product
    Table 154. Menarini Silicon Biosystems SpA Revenue in Precision Cancer Diagnostic Tests Business (2019-2024) & (US$ Million)
    Table 155. Menarini Silicon Biosystems SpA Recent Developments
    Table 156. Myriad Genetics Company Details
    Table 157. Myriad Genetics Business Overview
    Table 158. Myriad Genetics Precision Cancer Diagnostic Tests Product
    Table 159. Myriad Genetics Revenue in Precision Cancer Diagnostic Tests Business (2019-2024) & (US$ Million)
    Table 160. Myriad Genetics Recent Developments
    Table 161. NanoString Technologies Company Details
    Table 162. NanoString Technologies Business Overview
    Table 163. NanoString Technologies Precision Cancer Diagnostic Tests Product
    Table 164. NanoString Technologies Revenue in Precision Cancer Diagnostic Tests Business (2019-2024) & (US$ Million)
    Table 165. NanoString Technologies Recent Developments
    Table 166. Ortho Clinical Diagnostics Company Details
    Table 167. Ortho Clinical Diagnostics Business Overview
    Table 168. Ortho Clinical Diagnostics Precision Cancer Diagnostic Tests Product
    Table 169. Ortho Clinical Diagnostics Revenue in Precision Cancer Diagnostic Tests Business (2019-2024) & (US$ Million)
    Table 170. Ortho Clinical Diagnostics Recent Developments
    Table 171. QIAGEN N.V. Company Details
    Table 172. QIAGEN N.V. Business Overview
    Table 173. QIAGEN N.V. Precision Cancer Diagnostic Tests Product
    Table 174. QIAGEN N.V. Revenue in Precision Cancer Diagnostic Tests Business (2019-2024) & (US$ Million)
    Table 175. QIAGEN N.V. Recent Developments
    Table 176. Randox Laboratories Ltd. Company Details
    Table 177. Randox Laboratories Ltd. Business Overview
    Table 178. Randox Laboratories Ltd. Precision Cancer Diagnostic Tests Product
    Table 179. Randox Laboratories Ltd. Revenue in Precision Cancer Diagnostic Tests Business (2019-2024) & (US$ Million)
    Table 180. Randox Laboratories Ltd. Recent Developments
    Table 181. Roche Holding AG Company Details
    Table 182. Roche Holding AG Business Overview
    Table 183. Roche Holding AG Precision Cancer Diagnostic Tests Product
    Table 184. Roche Holding AG Revenue in Precision Cancer Diagnostic Tests Business (2019-2024) & (US$ Million)
    Table 185. Roche Holding AG Recent Developments
    Table 186. Royal Philips N.V. Company Details
    Table 187. Royal Philips N.V. Business Overview
    Table 188. Royal Philips N.V. Precision Cancer Diagnostic Tests Product
    Table 189. Royal Philips N.V. Revenue in Precision Cancer Diagnostic Tests Business (2019-2024) & (US$ Million)
    Table 190. Royal Philips N.V. Recent Developments
    Table 191. Siemens AG Company Details
    Table 192. Siemens AG Business Overview
    Table 193. Siemens AG Precision Cancer Diagnostic Tests Product
    Table 194. Siemens AG Revenue in Precision Cancer Diagnostic Tests Business (2019-2024) & (US$ Million)
    Table 195. Siemens AG Recent Developments
    Table 196. Thermo Fisher Scientific Company Details
    Table 197. Thermo Fisher Scientific Business Overview
    Table 198. Thermo Fisher Scientific Precision Cancer Diagnostic Tests Product
    Table 199. Thermo Fisher Scientific Revenue in Precision Cancer Diagnostic Tests Business (2019-2024) & (US$ Million)
    Table 200. Thermo Fisher Scientific Recent Developments
    Table 201. Vela Diagnostics Company Details
    Table 202. Vela Diagnostics Business Overview
    Table 203. Vela Diagnostics Precision Cancer Diagnostic Tests Product
    Table 204. Vela Diagnostics Revenue in Precision Cancer Diagnostic Tests Business (2019-2024) & (US$ Million)
    Table 205. Vela Diagnostics Recent Developments
    Table 206. Research Programs/Design for This Report
    Table 207. Key Data Information from Secondary Sources
    Table 208. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Precision Cancer Diagnostic Tests Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 2. Global Precision Cancer Diagnostic Tests Market Share by Type: 2023 VS 2030
    Figure 3. Imaging Features
    Figure 4. Molecular Features
    Figure 5. Histology/Cytology Features
    Figure 6. Tumor Marker Immunoassays Features
    Figure 7. POC Colon Cancer Tests Features
    Figure 8. Global Precision Cancer Diagnostic Tests Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 9. Global Precision Cancer Diagnostic Tests Market Share by Application: 2023 VS 2030
    Figure 10. Hospital Case Studies
    Figure 11. Clinic Case Studies
    Figure 12. Other Case Studies
    Figure 13. Precision Cancer Diagnostic Tests Report Years Considered
    Figure 14. Global Precision Cancer Diagnostic Tests Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 15. Global Precision Cancer Diagnostic Tests Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 16. Global Precision Cancer Diagnostic Tests Market Share by Region: 2023 VS 2030
    Figure 17. Global Precision Cancer Diagnostic Tests Market Share by Players in 2023
    Figure 18. Global Top Precision Cancer Diagnostic Tests Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Precision Cancer Diagnostic Tests as of 2023)
    Figure 19. The Top 10 and 5 Players Market Share by Precision Cancer Diagnostic Tests Revenue in 2023
    Figure 20. North America Precision Cancer Diagnostic Tests Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 21. North America Precision Cancer Diagnostic Tests Market Share by Type (2019-2030)
    Figure 22. North America Precision Cancer Diagnostic Tests Market Share by Application (2019-2030)
    Figure 23. North America Precision Cancer Diagnostic Tests Market Share by Country (2019-2030)
    Figure 24. United States Precision Cancer Diagnostic Tests Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 25. Canada Precision Cancer Diagnostic Tests Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 26. Europe Precision Cancer Diagnostic Tests Market Size YoY (2019-2030) & (US$ Million)
    Figure 27. Europe Precision Cancer Diagnostic Tests Market Share by Type (2019-2030)
    Figure 28. Europe Precision Cancer Diagnostic Tests Market Share by Application (2019-2030)
    Figure 29. Europe Precision Cancer Diagnostic Tests Market Share by Country (2019-2030)
    Figure 30. Germany Precision Cancer Diagnostic Tests Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. France Precision Cancer Diagnostic Tests Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. U.K. Precision Cancer Diagnostic Tests Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. Italy Precision Cancer Diagnostic Tests Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. Russia Precision Cancer Diagnostic Tests Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. Nordic Countries Precision Cancer Diagnostic Tests Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 36. China Precision Cancer Diagnostic Tests Market Size YoY (2019-2030) & (US$ Million)
    Figure 37. China Precision Cancer Diagnostic Tests Market Share by Type (2019-2030)
    Figure 38. China Precision Cancer Diagnostic Tests Market Share by Application (2019-2030)
    Figure 39. Asia Precision Cancer Diagnostic Tests Market Size YoY (2019-2030) & (US$ Million)
    Figure 40. Asia Precision Cancer Diagnostic Tests Market Share by Type (2019-2030)
    Figure 41. Asia Precision Cancer Diagnostic Tests Market Share by Application (2019-2030)
    Figure 42. Asia Precision Cancer Diagnostic Tests Market Share by Region (2019-2030)
    Figure 43. Japan Precision Cancer Diagnostic Tests Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. South Korea Precision Cancer Diagnostic Tests Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. China Taiwan Precision Cancer Diagnostic Tests Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. Southeast Asia Precision Cancer Diagnostic Tests Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 47. India Precision Cancer Diagnostic Tests Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 48. Australia Precision Cancer Diagnostic Tests Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 49. Middle East, Africa, and Latin America Precision Cancer Diagnostic Tests Market Size YoY (2019-2030) & (US$ Million)
    Figure 50. Middle East, Africa, and Latin America Precision Cancer Diagnostic Tests Market Share by Type (2019-2030)
    Figure 51. Middle East, Africa, and Latin America Precision Cancer Diagnostic Tests Market Share by Application (2019-2030)
    Figure 52. Middle East, Africa, and Latin America Precision Cancer Diagnostic Tests Market Share by Country (2019-2030)
    Figure 53. Brazil Precision Cancer Diagnostic Tests Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 54. Mexico Precision Cancer Diagnostic Tests Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 55. Turkey Precision Cancer Diagnostic Tests Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 56. Saudi Arabia Precision Cancer Diagnostic Tests Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 57. Israel Precision Cancer Diagnostic Tests Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 58. GCC Countries Precision Cancer Diagnostic Tests Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 59. Abbott Laboratories Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2019-2024)
    Figure 60. Agilent Technologies Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2019-2024)
    Figure 61. Becton Dickinson and Company Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2019-2024)
    Figure 62. Bio-Rad Laboratories Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2019-2024)
    Figure 63. Biocartis N.V. Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2019-2024)
    Figure 64. Biocept Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2019-2024)
    Figure 65. bioMerieux SA Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2019-2024)
    Figure 66. Canon Medical Systems Corporation Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2019-2024)
    Figure 67. Cynvenio Biosystems Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2019-2024)
    Figure 68. Danaher Corporation Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2019-2024)
    Figure 69. Epigenomics AG Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2019-2024)
    Figure 70. Exosome Diagnostics Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2019-2024)
    Figure 71. Foundation Medicine Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2019-2024)
    Figure 72. General Electric Company Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2019-2024)
    Figure 73. Genomic Health Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2019-2024)
    Figure 74. Hologic Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2019-2024)
    Figure 75. Illumina Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2019-2024)
    Figure 76. Menarini Silicon Biosystems SpA Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2019-2024)
    Figure 77. Myriad Genetics Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2019-2024)
    Figure 78. NanoString Technologies Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2019-2024)
    Figure 79. Ortho Clinical Diagnostics Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2019-2024)
    Figure 80. QIAGEN N.V. Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2019-2024)
    Figure 81. Randox Laboratories Ltd. Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2019-2024)
    Figure 82. Roche Holding AG Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2019-2024)
    Figure 83. Royal Philips N.V. Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2019-2024)
    Figure 84. Siemens AG Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2019-2024)
    Figure 85. Thermo Fisher Scientific Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2019-2024)
    Figure 86. Vela Diagnostics Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2019-2024)
    Figure 87. Bottom-up and Top-down Approaches for This Report
    Figure 88. Data Triangulation
    Figure 89. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Novocure

SIMILAR REPORTS

Global Precision Cancer Tests Market Research Report 2024
Precision Medicine Diagnostics Market
Global Breast Cancer Diagnostic Technologies Market Insights Forecast to 2030
Precision Cancer Imaging Market
Global Breast Cancer Diagnostic and Drug Technologies Market Insights Forecast to 2030
Global Ovarian Cancer Diagnostics Technologies Market Insights Forecast to 2030
Global In Vitro Diagnostics IVD Quality Control Product Market Insights Forecast to 2030
Global Epigenetics Diagnostic Market Insights Forecast to 2030
Global Women s Health Diagnostics Market Insights Forecast to 2030
Global Tumor Marker Testing Market Research Report 2024
Global In Vitro Diagnostic IVD Products Market Research Report 2024
Precision Cancer Diagnostic Solutions Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
In Vitro Diagnostic IVD Test Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Noninvasive Cancer Diagnostics and Technology Market Research Report 2025
Global In Vitro Diagnostics IVDs Medical Device Market Research Report 2025
Non Invasive Cancer Diagnostics Market
Noninvasive Cancer Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Hematology Oncology Diagnostics Market Research Report 2024
In Vitro Diagnostics IVD Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Next Generation IVD Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions